Effect of Herbal Supplement on Improving Sperm Virility

Exclusion Criteria

• •1. Employees working on night shifts.
• •2. Subjects with identifiable cause for Oligoasthenoteratozoospermia (OAT) (includes Cryptorchidism, Orchitis and Radiation or chemotherapy etc.).
• •3. Subjects with Systolic \>140 and Diastolic \>90 mmHg blood pressure and Fasting blood glucose (FBG) \>125 mg/dl.
• •4. Smokers and alcoholics.
• •5. Subjects underwent treatment for COVID 19 within the last 3 months or tested positive during the study will be excluded.
• •6. Subject with any physical disability that may limit sexual function.
• •7. Subjects with history of taking medications for oligospermia or any other sexual problems, including PDE-5 inhibitors, and dysfunctions related to genito-urinary system, muscular dystrophy and coagulation.
• •8. Subjects with clinical history of genital surgery, endocrine disorders e.g. hypopituitarism, pituitary tumors, hypo- and hyperthyroidism, hypogonadism, inherited (genetic and chromosomal) disorders, etc.
• •9. Subjects diagnosed with sleep apnea or related disorders.
• •10. Subjects consuming medications that can interfere with muscle mass such as corticosteroids, testosterone replacement or anabolic drugs.
• •11. Subjects who consume recreational drugs (such as cocaine, methamphetamine, marijuana, etc.) or chewable tobacco products.
• •12. Subjects having history of Benign Prostate Hyperplasia (BPH), stroke, myocardial infarction, coronary artery disease, cardiac failure, angina, life-threatening arrhythmia within the past 6 months.
• •13. Subjects under medications including vitamins, antidepressants, anticholinergics, inhaled beta agonists, anti- hyperlipidemic, psychotropics etc.
• •14. Subjects using any centrally acting anorectic agents, drugs that inhibit the absorption of nutrients and endocannabinoid neuromodulators during the two weeks prior to enrolment into the study.
• •15. Subjects who underwent major surgical procedures in last 6 months, which may affect their quality of life.
• •16. Subject with HIV positive or any other STDs.
• •17. History of psychiatric disorder that may impair the ability of subjects to provide written informed consent.
• •18. Subject has participated in a clinical study within the last 90 days prior to recruitment or concurrently participating in another study.